Table 4. Proteins expressed in different subgroups.
| Group | I | II | III | IV | V |
|---|---|---|---|---|---|
| TNF-a | 0.014±0.003 | 0.039±0.002* | 0.129±0.012*# | 0.384±0.021*#& | 0.671±0.036*#&▲ |
| NF-κB/p65 | 0.012±0.001 | 0.033±0.005* | 0.075±0.007*# | 0.182±0.145*#& | 0.191±0.013*#&▲ |
| BAX | 0.298±0.023 | 0.224±0.291* | 0.117±0.087*# | 0.055±0.051*#& | 0.022±0.006*#&▲ |
| BCL-2 | 0.126±0.101 | 0.186±0.015* | 0.325±0.022*# | 0.353±0.151*#& | 0.657±0.058*#&▲ |
TNF-α, NF-κB/p65, and BCL-2 levels were increased, as indicated by the number of embolizations and time after embolization, while BAX mRNAs expression showed the opposite trend, with statistically significant differences between the experimental groups. *, P<0.05 compared to group I; #, P<0.05 compared to group II; &, P<0.05 compared to group III; ▲, P<0.05 compared to group IV.